Start-up Zone

Is this start-up a game changer for drug discovery?  

18 January 2021

Jane Theaker, Kinomica explains why she was so impressed with the preclinical datasets predicting for drug response that the company could produce, she decided to join as CEO. Kinomica is a spin out offering phosphoproteomic analyses to the pharmaceutical industry. Theaker has R&D expertise in novel diagnostic technologies. Her experience includes genomics with AstraZeneca and […]

The start-up that knows one size doesn’t fit all

29 September 2020 , By Lu Rahman

Luis Valente, CEO & Co-Founder of iLoF, has been recognized by Forbes as one of the top 30 under 30 for science and healthcare. He told Lu Rahman what’s behind his start-up that recently secured $1 million in investment from Microsoft’s Venture Fund, M12 and Mayfield Fund and won the EIT Health Wild Card competition […]

Biorelate offers researchers free access to AI-based drug discovery tool

24 August 2020 , DDW editorial

The UK based AI start-up is offering all researchers free use of Galactic, its cloud-based web tool, to support biomedical research while lab access is restricted around the world. According to Biorelate, the cognitive computing platform behind Galactic can speed up the research process by collecting and curating more than 30 million biomedical research text […]

Start Codon debuts companies from life science business acceleration programme

24 August 2020

Start Codon, life science and healthcare business accelerator, has showcased its first cohort of start-ups. The company aims to minimise risk and translate early stage research into successful start-ups, ready for funding and partnership. Start Codon has been working closely with four life science and healthcare companies that were enrolled into the programme in February […]

AI start-up that speeds up drug discovery scoops $1 million investment

24 August 2020 , DDW editorial

Start-up iLoF (Intelligent Lab on Fiber), uses artificial intelligence (AI) and biophotonics to detect neurogenerative biomarkers and optimise the clinical trial selection process for diseases such as Alzheimer’s. iLoF also won the EIT Health Wild Card competition in 2019 and has secured $1 million in investment from Microsoft’s Venture Fund, M12 and Mayfield Fund. Following […]

« Previous